MedPath
HSA Approval

TACROLIMUS SANDOZ CAPSULE 0.5 MG

SIN15673P

TACROLIMUS SANDOZ CAPSULE 0.5 MG

TACROLIMUS SANDOZ CAPSULE 0.5 MG

April 25, 2019

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, GELATIN COATED

ORAL

Medical Information

L04AD02

tacrolimus

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Sandoz Private Limited

Active Ingredients

Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus

0.5 mg

Tacrolimus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.